Statements (57)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Research_Institute
|
gptkbp:aimsTo |
Improve_Patient_Outcomes
|
gptkbp:collaboratesWith |
Academic Institutions
|
gptkbp:conducts |
Clinical Trials
|
gptkbp:conductsResearchOn |
Anxiety Disorders
Depression Bipolar Disorder Schizophrenia Alzheimer's Disease |
gptkbp:contributedTo |
Drug Discovery
|
gptkbp:develops |
Medications for Mental Health Disorders
|
gptkbp:employs |
Scientists
|
gptkbp:engagesIn |
Collaborative Research Projects
|
gptkbp:focusesOn |
Pharmaceutical_Research
|
gptkbp:hasAccessTo |
Clinical_Data
|
gptkbp:hasCollaborationsWith |
Pharmaceutical Companies
|
gptkbp:hasEstablished |
Partnerships
|
gptkbp:hasPart |
Laboratories
Research Teams Research Facilities |
https://www.w3.org/2000/01/rdf-schema#label |
Lundbeck Research Germany
|
gptkbp:isActiveIn |
Public_Health_Initiatives
|
gptkbp:isAssociatedWith |
Lundbeck_Group
|
gptkbp:isEngagedIn |
Health_Economics_Research
|
gptkbp:isFocusedOn |
Neurodegenerative Diseases
|
gptkbp:isInvolvedIn |
Stakeholder Engagement
Epidemiological Studies Regulatory Affairs Pharmacogenomics Translational Medicine Preclinical Studies Health Technology Assessment Patient-Centric Research Patient Safety Research Post-marketing Studies Real-World Evidence Studies Patient Reported Outcomes Research Genetic_Research Neuroscience_Research Quality_of_Life_Studies Biomarker_Discovery Clinical_Practice_Guidelines_Development Market_Access_Research |
gptkbp:isKnownFor |
Innovative Therapies
Clinical_Research |
gptkbp:isLocatedIn |
gptkb:Heidelberg
|
gptkbp:isPartOf |
European_Research_Community
|
gptkbp:isRecognizedFor |
Scientific Excellence
|
gptkbp:isSupportedBy |
gptkb:Lundbeck_A/S
|
gptkbp:locatedIn |
gptkb:Germany
|
gptkbp:offers |
Internship Programs
|
gptkbp:participatesIn |
International_Conferences
|
gptkbp:partOf |
gptkb:Lundbeck_A/S
|
gptkbp:provides |
Research Funding
|
gptkbp:specializesIn |
Neurology
|
gptkbp:supports |
Patient Advocacy Groups
|
gptkbp:utilizes |
Advanced_Technologies
|